オンコリスバイオファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/07/09 | 2,855 | 2,881 | 2,611 | 2,620 | -245 | -8.6% | 1,747,400 |
2020/07/08 | 2,886 | 2,939 | 2,793 | 2,865 | -7 | -0.2% | 1,036,900 |
2020/07/07 | 2,762 | 2,906 | 2,760 | 2,872 | +10 | +0.3% | 1,259,900 |
2020/07/06 | 3,025 | 3,040 | 2,806 | 2,862 | -248 | -8% | 1,713,200 |
2020/07/03 | 2,911 | 3,160 | 2,911 | 3,110 | +140 | +4.7% | 806,600 |
2020/07/02 | 3,205 | 3,235 | 2,922 | 2,970 | -205 | -6.5% | 1,404,900 |
2020/07/01 | 3,190 | 3,275 | 3,120 | 3,175 | +5 | +0.2% | 576,900 |
2020/06/30 | 3,350 | 3,365 | 2,900 | 3,170 | -140 | -4.2% | 1,157,500 |
2020/06/29 | 3,235 | 3,370 | 3,225 | 3,310 | +5 | +0.2% | 680,200 |
2020/06/26 | 3,430 | 3,430 | 3,300 | 3,305 | -80 | -2.4% | 756,600 |
2020/06/25 | 3,365 | 3,530 | 3,250 | 3,385 | -50 | -1.5% | 2,301,300 |
2020/06/24 | 3,335 | 3,690 | 3,255 | 3,435 | +105 | +3.2% | 3,722,700 |
2020/06/23 | 3,750 | 3,820 | 3,305 | 3,330 | -370 | -10% | 5,680,200 |
2020/06/22 | 2,964 | 3,700 | 2,961 | 3,700 | +700 | +23.3% | 9,481,100 |
2020/06/19 | 2,519 | 3,000 | 2,513 | 3,000 | +500 | +20% | 1,919,600 |
2020/06/18 | 2,605 | 2,623 | 2,468 | 2,500 | -115 | -4.4% | 1,747,700 |
2020/06/17 | 2,617 | 2,800 | 2,517 | 2,615 | +298 | +12.9% | 8,426,200 |
2020/06/16 | 2,317 | 2,317 | 2,317 | 2,317 | +400 | +20.9% | 47,500 |
2020/06/15 | 2,077 | 2,184 | 1,900 | 1,917 | -159 | -7.7% | 1,107,000 |
2020/06/12 | 1,982 | 2,114 | 1,956 | 2,076 | -49 | -2.3% | 1,511,400 |
2020/06/11 | 2,263 | 2,298 | 2,100 | 2,125 | -179 | -7.8% | 2,075,300 |
2020/06/10 | 2,074 | 2,450 | 2,040 | 2,304 | +156 | +7.3% | 3,766,500 |
2020/06/09 | 2,050 | 2,177 | 2,007 | 2,148 | +101 | +4.9% | 1,883,100 |
2020/06/08 | 2,099 | 2,100 | 2,003 | 2,047 | +61 | +3.1% | 1,396,300 |
2020/06/05 | 2,018 | 2,160 | 1,967 | 1,986 | -100 | -4.8% | 4,637,900 |
2020/06/04 | 1,992 | 2,086 | 1,941 | 2,086 | +400 | +23.7% | 5,838,600 |
2020/06/03 | 1,700 | 1,702 | 1,633 | 1,686 | -4 | -0.2% | 440,700 |
2020/06/02 | 1,675 | 1,744 | 1,657 | 1,690 | +30 | +1.8% | 710,700 |
2020/06/01 | 1,650 | 1,673 | 1,611 | 1,660 | +12 | +0.7% | 400,600 |
2020/05/29 | 1,650 | 1,681 | 1,626 | 1,648 | -2 | -0.1% | 441,600 |
2020/05/28 | 1,700 | 1,721 | 1,604 | 1,650 | -90 | -5.2% | 1,336,900 |
2020/05/27 | 1,647 | 1,889 | 1,630 | 1,740 | +173 | +11% | 6,046,500 |
2020/05/26 | 1,611 | 1,612 | 1,542 | 1,567 | -47 | -2.9% | 464,400 |
2020/05/25 | 1,662 | 1,673 | 1,606 | 1,614 | -36 | -2.2% | 391,800 |
2020/05/22 | 1,591 | 1,650 | 1,586 | 1,650 | +50 | +3.1% | 513,600 |
2020/05/21 | 1,659 | 1,737 | 1,600 | 1,600 | +10 | +0.6% | 1,243,700 |
2020/05/20 | 1,566 | 1,599 | 1,520 | 1,590 | +40 | +2.6% | 685,200 |
2020/05/19 | 1,490 | 1,594 | 1,451 | 1,550 | +87 | +5.9% | 742,500 |
2020/05/18 | 1,415 | 1,469 | 1,397 | 1,463 | +63 | +4.5% | 278,700 |
2020/05/15 | 1,420 | 1,430 | 1,360 | 1,400 | -4 | -0.3% | 269,600 |
2020/05/14 | 1,433 | 1,476 | 1,392 | 1,404 | -24 | -1.7% | 323,800 |
2020/05/13 | 1,408 | 1,448 | 1,394 | 1,428 | +20 | +1.4% | 305,800 |
2020/05/12 | 1,380 | 1,533 | 1,370 | 1,408 | +38 | +2.8% | 850,900 |
2020/05/11 | 1,381 | 1,400 | 1,330 | 1,370 | -38 | -2.7% | 353,400 |
2020/05/08 | 1,451 | 1,452 | 1,376 | 1,408 | -17 | -1.2% | 372,900 |
2020/05/07 | 1,351 | 1,447 | 1,351 | 1,425 | +47 | +3.4% | 391,500 |
2020/05/01 | 1,341 | 1,388 | 1,312 | 1,378 | +23 | +1.7% | 287,900 |
2020/04/30 | 1,383 | 1,406 | 1,352 | 1,355 | -12 | -0.9% | 354,600 |
2020/04/28 | 1,317 | 1,378 | 1,314 | 1,367 | +42 | +3.2% | 230,100 |
2020/04/27 | 1,299 | 1,339 | 1,278 | 1,325 | +40 | +3.1% | 215,400 |
1201~
1250
件表示中 / 2808件
類似銘柄と比較する
現在ご覧いただいている「オンコリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
オンコリス | 66,400円 | +3771.0% | - | 0.00% | - | 6.01倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
ステムリム | 30,800円 | - | - | 0.00% | - | 2.84倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
CANBAS | 93,200円 | - | - | 0.00% | - | 5.96倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
ラクオリア | 62,800円 | +25.1% | - | 0.00% | - | 2.77倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
Chordia | 22,100円 | - | - | 0.00% | - | 4.70倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム